+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prevalence of diagnosed HIV disease among medicaid beneficiaries with schizophrenia in U.S. metropolitan areas

Prevalence of diagnosed HIV disease among medicaid beneficiaries with schizophrenia in U.S. metropolitan areas

Journal of Nervous and Mental Disease 198(9): 682-686

Numerous reports suggest HIV may be elevated among those with severe mental illnesses such as schizophrenia or bipolar illness, but this has been studied in only a limited number of sites. Medicaid claim's files from 2002 to 2003 were examined for metropolitan statistical areas (MSAs) in 8 states, focusing on schizophrenia. Across 102 MSAs, 1.81% of beneficiaries with schizophrenia had received diagnoses of HIV/AIDS. MSA rates ranged widely, from 5.2% in Newark, NJ, to no cases in 16 of the MSAs.

(PDF emailed within 0-6 h: $19.90)

Accession: 055157218

Download citation: RISBibTeXText

PMID: 20823732

DOI: 10.1097/NMD.0b013e3181ef21a2

Related references

Use of Medicaid data to explore community characteristics associated with HIV prevalence among beneficiaries with schizophrenia. Public Health Reports 126 Suppl 3(): 89-101, 2011

Potential adult Medicaid beneficiaries under the Patient Protection and Affordable Care Act compared with current adult Medicaid beneficiaries. Annals of Family Medicine 11(5): 406-411, 2014

Medication continuity among Medicaid beneficiaries with schizophrenia and bipolar disorder. Psychiatric Services 64(9): 878-885, 2014

Assisted living and use of health services among medicaid beneficiaries with schizophrenia. Journal of Mental Health Policy and Economics 6(2): 59-65, 2003

Incidence and consistency of antiretroviral use among HIV-infected medicaid beneficiaries with schizophrenia. Journal of Clinical Psychiatry 62(3): 174-178, 2001

Outcomes for Medicaid beneficiaries with schizophrenia under a prepaid mental health carve-out. Journal of Behavioral Health Services & Research 26(4): 442-450, 1999

Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations. Psychiatric Services 66(2): 127-133, 2015

State and demographic variation in use of depot antipsychotics by Medicaid beneficiaries with schizophrenia. Psychiatric Services 65(1): 121-124, 2014

State Variation in the Delivery of Comprehensive Services for Medicaid Beneficiaries with Schizophrenia and Bipolar Disorder. Community Mental Health Journal 51(5): 523-534, 2016

Antipsychotic polypharmacy trends among Medicaid beneficiaries with schizophrenia in San Diego County, 1999-2004. Psychiatric Services 58(7): 1007-1010, 2007

Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry 161(4): 692-699, 2004

Emergency department utilization among Medicaid beneficiaries with schizophrenia and diabetes: the consequences of increasing medical complexity. Schizophrenia Research 152(2-3): 490-497, 2014

A longitudinal study of the prevalence of migraine headaches among Idaho Medicaid beneficiaries. American Journal of Epidemiology 151(11 Supplement): S45, June 1, 2000

The relationship of antipsychotic medication class and adherence with treatment outcomes and costs for Florida Medicaid beneficiaries with schizophrenia. Administration and Policy in Mental Health 34(3): 307-314, 2007

Coronary heart disease prevalence and occupational structure in U.S. metropolitan areas: a multilevel analysis. Health & Place 21: 192-204, 2014